Cawachi Limited

2664.T
Pharmaceutical Retailers
2026/09/21 Updated
Market Cap: $518.7M (¥81.4B)
Stock Price: $23.70 (¥3,720)
Exchange Rate: 1 USD = ¥156.99

Notice Regarding the Results of treasury stock acquisition and the termination of the acquisition

From August 12, 2026 to September 1, 2026, the company acquired 532,400 ordinary shares as treasury stock through market purchases for a total of 1,999,802,000 yen. The upper limit was 700,000 shares (3.13% of issued shares) and up to 2,000,000,000 yen; the planned acquisition period was August 12, 2026 to September 7, 2026 (resolutions date), but the actual acquisition ended on September 1.

Importance:
Page Updated: September 2, 2026
IR Disclosure Date: September 2, 2026

Key Figures

  • 532,400 株: 取得株式数
  • 1,999,802,000 円: 取得総額
  • 上限700,000 株(3.13%)/ 2,000,000,000 円: 上限情報

AI要約

Summary of the acquisition

Today, we announce the execution of treasury stock acquisition under Article 165, Paragraph 2 of the Companies Act. The target is the company's ordinary shares, with the acquisition period from August 12, 2026 to September 1, 2026, total shares 532,400, and total amount 1,999,802,000 yen. The transactions were conducted via market purchases on the Tokyo Stock Exchange.

Outlook and notes

At the Board of Directors meeting held on August 3, the upper limit was set at 700,000 shares (3.13% of issued shares) and up to 2,000,000,000 yen, with a period from August 12 to September 7. This acquisition is a realized portion or entirety of that plan, ending within the established upper limits for both amount and shares. We will monitor market trends and potential dilution effects if further disclosures are made.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Cawachi Limited

Company overview · Stock price · Financial data · All IR

View company page →